心脏瓣膜病合并巨大左心室围术期处理  

Perioperative period management of valvular heart disease combined with giant left ventricle

作　　者：封赞祥[1] 王玉玖[1] 董圣军[1] 刘宝辉[1] 吴恩刚 

机构地区：[1]滨州医学院附属医院心脏外科,滨州256603

出　　处：《滨州医学院学报》2015年第6期443-445,共3页Journal of Binzhou Medical University

摘　　要：目的探讨心脏瓣膜病合并巨大左心室围术期处理的新特点。方法回顾性分析2008年1月至2013年1月24例巨大左心室患者心脏瓣膜手术的临床资料以及围手术期的处理。结果本组24例病人,术后恢复均顺利,术后24例病人无低心排、室颤并发症,且与术前相比,患者术后1月的LVEDD与LVESD显著性地减少(P<0.05),而LVEF显著性地提高(P<0.05)。对其术前手术指征的评估,术前改善心脏功能的治疗,术后早期的处理等围手术期的处理的特点进行了总结。结论选择合适的手术时机,围术期正确处理是提高这类巨大心室患者心脏瓣膜手术疗效的关键。Objective To explore new features of perioperative period management in valvular heart disease combined with giant left ventricle.Methods The clinical data and perioperative period management in 24 patients from January 2008 to January 2013 were retrospectively reviewed.Results Twenty four patients successfully recovered after operation,without low cardiac output syndrome or ventricular fibrillation.One month after operation,LVEDD and LVESD decreased significantly in all patients,while left ventricular ejection fraction（LVEF）increased significantly.We summarized the evaluation indications of operation,pre-operation and postoperation treatment.Conclusion To choose appropriate operation opportunity and handle correctly perioperative period can improve the efficacy of ventricular cardiac valve surgery.

关 键 词：心脏瓣膜病 巨大左心室 围术期 

分 类 号：R654.2[医药卫生—外科学]